{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:53:39Z","timestamp":1793429619269,"version":"4.5.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    With ageing populations, the prevalence of different types of dementias is increasing. The pathology of Alzheimer\u2019s disease (AD), the most common form of dementia, has been linked to the presence of plaques and neurofibrillary tangles in the central nervous system of patients. There are growing indications that risk of developing dementia correlates with several infectious agents, including human herpes viruses, flaviviruses and SARS-CoV-2. This has led to a proposition that AD and other dementias could be considered as having an infectious disease etiology. Whilst the mechanisms behind this remain unclear, intriguing epidemiological data suggest that several vaccinations are correlated with\n                    <jats:italic>reduced<\/jats:italic>\n                    risk for dementia. Intravesicular administration of the tuberculosis vaccine strain Bacille Calmette-Gu\u00e9rin (BCG) has been associated with decreased risk of dementia in bladder cancer patients. This has led to the hypothesis that non-specific effects of vaccinations, mediated through trained innate immunity, provide a mechanistic explanation. Over the last few years, the AS01-adjuvanted recombinant shingles vaccine has also been associated with reduced risk in several studies. Moreover, in a recent study, immunization with the adjuvanted RSV vaccine, also containing AS01, was shown to reduce risk of dementia. Integrating data on BCG and mechanistic hypotheses, recent findings on the AS01 adjuvant, and the role of trained innate immunity, we describe here an immunological model that connects vaccine and adjuvant mode of action with risk of dementia. This immunological model can help shape a research roadmap to further elucidate the mechanisms behind the collective epidemiological data.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1748535","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:42:31Z","timestamp":1772602951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Infection, vaccination and risk of dementia: a proposed immunological model"],"prefix":"10.3389","volume":"17","author":[{"given":"Justin","family":"Devine","sequence":"first","affiliation":[{"name":"Synexa Life Sciences","place":["Cape Town, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Center for Vaccinology (CEVAC), Ghent University and Ghent University Hospital","place":["Ghent, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Leroux-Roels","sequence":"additional","affiliation":[{"name":"Center for Vaccinology (CEVAC), Ghent University and Ghent University Hospital","place":["Ghent, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Leroux-Roels","sequence":"additional","affiliation":[{"name":"Center for Vaccinology (CEVAC), Ghent University and Ghent University Hospital","place":["Ghent, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"van der Most","sequence":"additional","affiliation":[{"name":"VaxxCellence","place":["Antwerp, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"B1","unstructured":"Dementia\n          \n          \n          \n          2025"},{"key":"B2","unstructured":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1186\/s12877-024-05538-5","article-title":"Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis","volume":"24","author":"Shan","year":"2024","journal-title":"BMC Geriatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102068","DOI":"10.1016\/j.arr.2023.102068","article-title":"Alzheimer\u2019s disease as a viral disease: Revisiting the infectious hypothesis","volume":"91","author":"Bruno","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuron.2019.12.031","article-title":"Human herpesvirus 6 detection in alzheimer\u2019s disease cases and controls across multiple cohorts","volume":"105","author":"Allnutt","year":"2020","journal-title":"Neuron"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00682-4","article-title":"Proteomics identifies potential immunological drivers of postinfection brain atrophy and cognitive decline","volume":"4","author":"Duggan","year":"2024","journal-title":"Nat Aging"},{"key":"B7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.17879\/freeneuropathology-2021-3347","article-title":"Viral infection and dementia: A brief synthesis","volume":"2","author":"Wiley","year":"2021","journal-title":"Free Neuropathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"103340","DOI":"10.1016\/j.drudis.2022.103340","article-title":"Recent insights into viral infections as a trigger and accelerator in alzheimer\u2019s disease","volume":"27","author":"De Vlieger","year":"2022","journal-title":"Drug Discov Today"},{"key":"B9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/pathogens13110974","article-title":"Infectious disease as a modifiable risk factor for dementia: A narrative review","volume":"13","author":"Farrer","year":"2024","journal-title":"Pathogens"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70037","article-title":"Data-driven discovery of associations between prescribed drugs and dementia risk: A systematic review","volume":"11","author":"Underwood","year":"2025","journal-title":"Alzheimers Dement (N Y)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1941","article-title":"Risk of dementia following herpes zoster infection among patients undertreatment versus those not: A systematic review and meta-analysis","volume":"7","author":"Thapa","year":"2024","journal-title":"Health Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-31978-5_28","article-title":"Infections, vaccinations, and risk of alzheimer\u2019s disease (AD)\/dementia: probable involvement of reactivated herpes simplex virus type 1","volume":"1423","author":"Itzhaki","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03972-5","article-title":"Varicella-zoster virus reactivation and the risk of dementia","volume":"31","author":"Polisky","year":"2025","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2546741","DOI":"10.1080\/21645515.2025.2546741","article-title":"Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis","volume":"21","author":"Marra","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12119","article-title":"Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden","volume":"7","author":"Lopatko Lindman","year":"2021","journal-title":"Alzheimers Dement (N Y)"},{"key":"B16","unstructured":"EurekAlert! Antiviral treatment fails to slow early-stage Alzheimer\u2019s\n          \n          \n          2025"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1243588","article-title":"The role of Bacillus Calmette-Guerin administration on the risk of dementia in bladder cancer patients: a systematic review and meta-analysis","volume":"15","author":"Han","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-231323","article-title":"Vaccines and dementia: part II. Efficacy of BCG and other vaccines against dementia","volume":"98","author":"Greenblatt","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2216625","DOI":"10.1080\/21645515.2023.2216625","article-title":"Do vaccinations influence the development of Alzheimer disease","volume":"19","author":"Bukhbinder","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"B20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41422-025-01171-y","article-title":"Trained immunity: induction of an inflammatory memory in disease","volume":"35","author":"Schluter","year":"2025","journal-title":"Cell Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-231315","article-title":"Vaccines and dementia: part I. Non-specific immune boosting with BCG: history, ligands, and receptors","volume":"98","author":"Greenblatt","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1016\/j.cell.2021.05.039","article-title":"The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination","volume":"184","author":"Wimmers","year":"2021","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl3381","article-title":"Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine","volume":"16","author":"Bechtold","year":"2024","journal-title":"Sci Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1662314","article-title":"Vaccine research in cognitive impairment and dementia: a bibliometric analysis and future outlook (2000-2025)","volume":"16","author":"Wang","year":"2025","journal-title":"Front Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"796867","DOI":"10.1080\/19490976.2025.2501193","article-title":"The impact of systemic inflammation on alzheimer\u2019s disease pathology","volume":"12","author":"Xie","year":"2021","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13195-025-01825-4","article-title":"Metabolic syndrome and risk of incident all-cause dementia, Alzheimer\u2019s disease and vascular dementia: a systematic review and meta-analysis of longitudinal studies","volume":"17","author":"Qureshi","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13439","article-title":"Association between metabolic syndrome and risk of incident dementia in UK Biobank","volume":"20","author":"Qureshi","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100652","DOI":"10.1016\/j.lanhl.2024.100652","article-title":"Role of age and exposure duration in the association between metabolic syndrome and risk of incident dementia: a prospective cohort study","volume":"5","author":"Qureshi","year":"2024","journal-title":"Lancet Healthy Longev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"120554","DOI":"10.1016\/j.atherosclerosis.2025.120554","article-title":"Inflammation mediates the association between metabolic syndrome and vascular dementia: A large prospective cohort study","volume":"411","author":"Jiang","year":"2025","journal-title":"Atherosclerosis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-025-02014-9","article-title":"Metabolic syndrome and risk of dementia and cognitive decline: a systematic review and meta-analysis of prospective cohort studies from 6,753,197 participants","author":"Wang","year":"2025","journal-title":"Geroscience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"101982","DOI":"10.1016\/j.xcrm.2025.101982","article-title":"The gut microbiota-immune-brain axis: Therapeutic implications","volume":"6","author":"O\u2019Riordan","year":"2025","journal-title":"Cell Rep Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111515","article-title":"Gut microbiota regulates blood-cerebrospinal fluid barrier function and Abeta pathology","volume":"42","author":"Xie","year":"2023","journal-title":"EMBO J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1582119","article-title":"Gut microbiota-driven neuroinflammation in Alzheimer\u2019s disease: from mechanisms to therapeutic opportunities","volume":"16","author":"Lei","year":"2025","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e20241232","DOI":"10.1084\/jem.20241232","article-title":"Lipid metabolism and neuroinflammation: What is the link","volume":"222","author":"Tiwari","year":"2025","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1583886","article-title":"NLRP3 inflammasome in Alzheimer\u2019s disease: molecular mechanisms and emerging therapies","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-221231","article-title":"The impact of routine vaccinations on alzheimer\u2019s disease risk in persons 65 years and older: A claims-based cohort study using propensity score matching","volume":"95","author":"Harris","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1186\/s12889-023-16768-4","article-title":"The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink","volume":"23","author":"Lophatananon","year":"2023","journal-title":"BMC Public Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"afaf169","DOI":"10.1093\/ageing\/afaf169","article-title":"Influenza vaccination and risk of dementia: a systematic review and meta-analysis","volume":"54","author":"Yang","year":"2025","journal-title":"Age Ageing"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac484","article-title":"Common vaccines and the risk of incident dementia: A population-based cohort study","volume":"227","author":"Douros","year":"2023","journal-title":"J Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac487","article-title":"Commentary on \u201cCommon Vaccines and the Risk of Dementia: A Population-Based Cohort Study\u201d: Science Can be Messy but Eventually Leads to Truths","volume":"227","author":"Salmon","year":"2023","journal-title":"J Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03201-5","article-title":"The recombinant shingles vaccine is associated with lower risk of dementia","volume":"30","author":"Taquet","year":"2024","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08800-x","article-title":"A natural experiment on the effect of herpes zoster vaccination on dementia","volume":"641","author":"Eyting","year":"2025","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12293","article-title":"Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020","volume":"8","author":"Schnier","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3415","article-title":"Herpes zoster vaccination and the risk of dementia: A systematic review and meta-analysis","volume":"14","author":"Shah","year":"2024","journal-title":"Brain Behav"},{"key":"B46","doi-asserted-by":"publisher","first-page":"126673","DOI":"10.1016\/j.vaccine.2024.126673","article-title":"Recombinant zoster vaccine and the risk of dementia","volume":"46","author":"Tang","year":"2025","journal-title":"Vaccine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1016\/j.cell.2025.11.007","article-title":"The effect of shingles vaccination at different stages of the dementia disease course","volume":"188","author":"Xie","year":"2025","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41541-025-01172-3","article-title":"Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections","volume":"10","author":"Taquet","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B49","unstructured":"GSK highlights new findings on Dementia and Alzheimer\u2019s Disease at AAIC 2025, building on leadership in immunology and inflammation\n          \n          \n          \n          2025"},{"key":"B50","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41541-025-01312-9","article-title":"Reply to: Methodological Issues in Taquet et\u00a0al.\u2018s analysis preclude any conclusions regarding AS01 adjuvant\u2019s specific role in dementia prevention","volume":"10","author":"Taquet","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41541-025-01309-4","article-title":"Methodological Issues in Taquet et\u00a0al.\u2018s analysis preclude any conclusions regarding AS01 adjuvant\u2019s specific role in dementia prevention","volume":"10","author":"Williams","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41577-025-01132-x","article-title":"Trained immunity in chronic inflammatory diseases and cancer","volume":"25","author":"Hajishengallis","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.immuni.2025.05.020","article-title":"A conserved immune dysregulation signature is associated with infection severity, risk factors prior to infection, and treatment response","volume":"58","author":"Ganesan","year":"2025","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1038\/s41598-024-55423-9","article-title":"Mechanistic insights into the role of amyloid-beta in innate immunity","volume":"14","author":"Prosswimmer","year":"2024","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.11.043","article-title":"Alzheimer\u2019s Disease-Associated beta-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection","volume":"100","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"B56","doi-asserted-by":"publisher","first-page":"115109","DOI":"10.1016\/j.celrep.2024.115109","article-title":"Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer\u2019s disease","volume":"44","author":"Hyde","year":"2025","journal-title":"Cell Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"102535","DOI":"10.1016\/j.xcrm.2025.102535","article-title":"Pharmacologic reversal of advanced Alzheimer\u2019s disease in mice and identification of potential therapeutic nodes in human brain","volume":"7","author":"Chaubey","year":"2025","journal-title":"Cell Rep Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2025.07.003","article-title":"Shingles vaccination and neuroimmune vulnerability","volume":"48","author":"Huang","year":"2025","journal-title":"Trends Neurosci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer\u2019s disease","volume":"14","author":"Moir","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B60","doi-asserted-by":"publisher","first-page":"12699","DOI":"10.3390\/ijms241612699","article-title":"Blood-brain barrier breakdown in neuroinflammation: current in vitro models","volume":"24","author":"Brandl","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab633","article-title":"Recombinant adjuvanted zoster vaccine and reduced risk of coronavirus disease 2019 diagnosis and hospitalization in older adults","volume":"225","author":"Bruxvoort","year":"2022","journal-title":"J Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac310","article-title":"Reply to Chu et\u00a0al","volume":"227","author":"Ackerson","year":"2023","journal-title":"J Infect Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/infdis\/jiac309","article-title":"Correspondence to recombinant adjuvanted zoster vaccine and reduced risk of coronavirus disease 2019 diagnosis and hospitalization in older adults","volume":"227","author":"Chu","year":"2023","journal-title":"J Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-00990-1","article-title":"Integrated organ immunity: a path to a universal vaccine","volume":"24","author":"Pulendran","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41590-023-01700-0","article-title":"BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance","volume":"25","author":"Lee","year":"2024","journal-title":"Nat Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"eaay8618","DOI":"10.1126\/scitranslmed.aay8618","article-title":"Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature","volume":"12","author":"De Mot","year":"2020","journal-title":"Sci Transl Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.02.015","article-title":"Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans","volume":"37","author":"Burny","year":"2019","journal-title":"Vaccine"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00943","article-title":"Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans","volume":"8","author":"Burny","year":"2017","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNgamma response promoting vaccine immunogenicity","volume":"2","author":"Coccia","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102710","article-title":"Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S\/AS01 malaria vaccine","volume":"188","author":"Horowitz","year":"2012","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","article-title":"Virus exposure and neurodegenerative disease risk across national biobanks","volume":"111","author":"Levine","year":"2023","journal-title":"Neuron"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1215165110","article-title":"Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer\u2019s disease-related pathology","volume":"110","author":"Michaud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.06.031","article-title":"Single-cell multiregion epigenomic rewiring in Alzheimer\u2019s disease progression and cognitive resilience","author":"Liu","year":"2025","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1748535\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:42:34Z","timestamp":1772602954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1748535\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2026.1748535"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1748535","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1748535"}}